OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Therapeutic drug monitoring
Pharmacogenetic and Pharmacogenomics
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Project:
Cancer
Categories:
Observational
Highlighted
17 Publications
found
First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.
b
JAMA network open
July 3, 2023
p
Cancer
c
Change patient management
Highlighted
Observational
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
b
EClinicalMedicine
June 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
b
The lancet. Gastroenterology & hepatology
January 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.
b
Cancer discovery
November 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
b
British journal of cancer
October 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.
b
BMC medicine
October 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor-based regimens.
b
JCI insight
January 11, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
b
The Lancet. Oncology
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
b
Nature communications
October 2, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
b
The Lancet. Oncology
April 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
1
2
Next Page